- Lobbying
- Lobbying by Sun Pharmaceutical Industries, Ltd.
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
John McMickle | Counsel, Senate Judiciary Committee |
Eric Silva | Legislative Aide, Senate EPW Committee & Senator Jeffords |
John Waits | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Amendment
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Amendment
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Registration
Issue(s) they said they’d lobby about: Legislative and Executive branch matters pertaining to the above issue areas, including matters realted to citizens petitions filed at the FDA with the effect of keeping generic drugs from timely entering the market..
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate